OverviewSuggest Edit

AtriCure provides atrial fibrillation solutions to medical centers. The Company offers innovative solutions for ablation, such as Isolator Synergy and Isolator Synergy Access clamps, COBRA Fusion surgical ablation system and EPi-Sense guided coagulation system. It also provides SUBTLE cannula, multifunctional pens and linear ablation devices. In addition, the Company offers cryoICE cryoablation system, AtriClip system, Lumitip dissector and Estech cardiac surgery instruments.
TypePublic
Founded2000
HQMason, US
Websiteatricure.com
Employee Ratings3.9

Latest Updates

Employees (est.) (Jan 2019)620(+9%)
Job Openings40
Revenue (FY, 2018)$201.6 M(+16%)
Share Price (Jun 2019)$29.9 (+3%)

Key People/Management at AtriCure

Michael Carrel

Michael Carrel

President & CEO
Douglas Seith

Douglas Seith

COO
Andrew Wade

Andrew Wade

Vp & CFO
Sam Privitera

Sam Privitera

CTO
Karl Dahlquist

Karl Dahlquist

Vice President, Legal and Chief Compliance Officer
Tonya Austin

Tonya Austin

Vice President, Human Resources
Show more

AtriCure Office Locations

AtriCure has offices in Mason, Allentown, Allen, Dallas and in 28 other locations
Mason, US (HQ)
7555 Innovation Way
Albany, US
Albany, NY, USA
Allen, US
Allen, TX, USA
Allentown, US
Allentown, PA, USA
Boston, US
Boston, MA, USA
Chicago, US
Chicago, IL, USA
Show all (32)

AtriCure Financials and Metrics

AtriCure Revenue

Embed Graph
View revenue for all periods
AtriCure's revenue was reported to be $201.63 m in FY, 2018
USD

Revenue (Q2, 2019)

58.9m

Gross profit (Q2, 2019)

43.9m

Gross profit margin (Q2, 2019), %

74.5%

Net income (Q2, 2019)

(4.1m)

EBIT (Q2, 2019)

(3.8m)

Market capitalization (10-Jun-2019)

1.2b

Closing stock price (10-Jun-2019)

29.9

Cash (30-Jun-2019)

25.2m

EV

1.2b
AtriCure's current market capitalization is $1.2 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

81.9m107.5m129.8m155.1m174.7m201.6m

Revenue growth, %

31%21%20%

Cost of goods sold

22.3m31.7m36.9m44.0m48.6m54.5m

Gross profit

59.6m75.8m92.9m111.1m126.2m147.1m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

20.1m24.8m26.5m26.7m29.9m32.6m31.4m35.9m39.7m38.3m41.3m45.2m42.2m47.0m51.8m54.0m58.9m

Cost of goods sold

5.5m7.2m7.7m7.8m8.2m9.5m8.9m10.0m10.9m10.9m11.3m12.7m11.2m12.5m13.7m14.0m14.1m15.0m

Gross profit

14.7m17.7m18.8m18.9m21.7m23.1m22.5m25.9m28.8m27.5m30.0m32.6m30.9m34.5m38.1m39.9m43.9m

Gross profit Margin, %

73%71%71%71%73%71%72%72%73%72%73%72%73%73%74%74%75%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

14.9m28.4m23.8m24.2m21.8m32.2m

Accounts Receivable

Inventories

10.2m14.3m17.7m17.7m22.5m22.5m

Current Assets

52.5m93.5m74.8m85.7m82.3m174.7m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(11.5m)(16.2m)(27.2m)(33.3m)(26.9m)(21.1m)

Depreciation and Amortization

2.0m4.8m6.3m9.3m9.1m8.8m

Inventories

(2.3m)(4.3m)(2.9m)(79.0k)(4.5m)(146.0k)

Accounts Payable

1.4m(944.0k)4.0m(1.1m)1.3m(2.4m)
USDY, 2019

EV/EBIT

-267 x

EV/CFO

-105.8 x

Financial Leverage

1.4 x
Show all financial metrics

AtriCure Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
SentreHEARTAugust 15, 2019$300 m

AtriCure Online and Social Media Presence

Embed Graph

AtriCure News and Updates

Tipper Trucks Global Market 2018-2025: BELAZ, Caterpillar, Komatsu, Abbott Vascular, AtriCure

Wiseguyreports.Com Publish New Market Research Report On -“Tipper Trucks Market - Global Industry Analysis, Size, Share, Trends, Growth and Forecast 2018 - 2025” Posted via Industry Today. Follow us on Twitter @IndustryToday

Ablation Technologies Market Size, Growth rate, Market Statistics and Future Forecasts to 2023

The report depicts the global and regional total market of Ablation Technologies industry including capacity, production, production value, cost/profit, supply/demand and import/export details. Posted via Industry Today. Follow us on Twitter @IndustryToday

New Research Report On Epicardial LAA Closure Device Market Analysis, Market Size, Regional Outlook, Competitive Strategies and Forecasts, to 2021, Focusing on Top Key Vendors like AtriCure, Boston Scientific, St. Jude, Coherex Medical, Lifetech Scientifi

Epicardial LAA (Left Atrial Appendage) Closure Device Market by Product (Epicardial LAA Closure Device and Endocardial LAA Closure Device) and End User (Hospitals, Ambulatory Surgical Centers, and Heart Clinics) - Global Opportunity Analysis and Industry Forecast, 2017-2021Top Companies Profiled in …

Left Atrial Appendage (LAA) Closure Devices Market to Make Great Impact in Near Future by 2025

The North America is dominating and contributed the leading shares to the global left atrial appendage (LAA) closure devices market in terms of revenue and expected to register a significant growth during forecast period. Posted via Industry Today. Follow us on Twitter @IndustryToday

AtriCure Blogs

AtriCure could pay up to $300M to acquire California firm

[ AtriCure, Inc. ]Mason-based medical device maker AtriCure expects to close the deal in the next few days.Reference Source

AtriCure Enters Into Definitive Agreement to Acquire SentreHEART | AtriCure, Inc.

[ AtriCure, Inc. ]The Investor Relations website contains information about AtriCure, Inc.'s business for stockholders, potential investors, and financial analysts.Reference Source

ACT against Afib

[ AtriCure, Inc. ]Jack, a coronary artery bypass patient with concomitant surgical ablation (SA), and his wife share their story and why they are happy he received SA with his quadruple bypass. His surgeon, Dr. Gregory, also shares his perspective on how technology has advanced and why he’s passiona…

Help for hearts - American entity provides free surgery for 10 Jamaicans

[ AtriCure, Inc. ]Kerrian Clarke-Wilson and Vanessa Rowe are breathing easier today having benefited from surgeries to treat the potentially fatal rheumatiReference Source

AtriCure, Inc.'s cover photo

[ AtriCure, Inc. ] Reference Source

Where a Sore Throat Becomes a Death Sentence

[ AtriCure, Inc. ]Once a year, doctors travel to Rwanda to perform lifesaving surgery on people with damaged heart valves — a disease caused by untreated strep throat.Reference Source
Show more

AtriCure Frequently Asked Questions

  • When was AtriCure founded?

    AtriCure was founded in 2000.

  • Who are AtriCure key executives?

    AtriCure's key executives are Michael Carrel, Douglas Seith and Andrew Wade.

  • How many employees does AtriCure have?

    AtriCure has 620 employees.

  • What is AtriCure revenue?

    Latest AtriCure annual revenue is $201.6 m.

  • What is AtriCure revenue per employee?

    Latest AtriCure revenue per employee is $325.2 k.

  • Who are AtriCure competitors?

    Competitors of AtriCure include Mirabilis Medical, Cohera Medical and Medistim.

  • Where is AtriCure headquarters?

    AtriCure headquarters is located at 7555 Innovation Way, Mason.

  • Where are AtriCure offices?

    AtriCure has offices in Mason, Allentown, Allen, Dallas and in 28 other locations.

  • How many offices does AtriCure have?

    AtriCure has 32 offices.